The Change of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Patients with Glioma during Radiotherapy and Impact on Clinical Outcome-论文-万方医学网

首页> > The Change of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Patients with Glioma during Radiotherapy and Impact on Clinical Outcome

The Change of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Patients with Glioma during Radiotherapy and Impact on Clinical Outcome

导出原文传递

翻译打印收藏纠错

第一作者： Ding, X.

作者： Ding, X. ^[1] ; Zhu, Y. ^[2] ; Zhang, X. ^[3] ; Nie, S. ^[4] ; Zhou, Z. ; Guo, Y. ; Yu, J. ; Hu, M.

作者单位： Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Peoples R China ^[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Neurosurg, Jinan ^[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol ^[3] Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Peoples R China ^[4]

发布时间 2022-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The Change of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Patients with Glioma during Radiotherapy and Impact on Clinical Outcome

相似文献

同项目论文

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The Change of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Patients with Glioma during Radiotherapy and Impact on Clinical Outcome

相似文献

同项目论文

相关期刊

检索历史清除